Pieris Pharmaceuticals (NASDAQ:PIRS) Research Coverage Started at StockNews.com

StockNews.com initiated coverage on shares of Pieris Pharmaceuticals (NASDAQ:PIRS – Free Report) in a report published on Sunday morning. The brokerage issued a hold rating on the biotechnology company’s stock. Pieris Pharmaceuticals Stock Down 2.8 % NASDAQ:PIRS opened at $0.18 on Friday. The stock’s 50 day moving average price is $0.21 and its two-hundred day […]

Related Keywords

,News Ratings For Pieris Pharmaceuticals Daily ,Pieris Pharmaceuticals Company Profile ,Raymond James Associates ,Mirabella Financial Services ,Tower Research Capital ,Nasdaq ,Oppenheimer Co ,Pieris Pharmaceuticals Inc ,Institutional Investors Weigh In On Pieris Pharmaceuticals ,Pieris Pharmaceuticals ,Pieris Pharmaceuticals Stock Down ,Free Report ,Pharmaceuticals Stock Down ,Get Free Report ,Research Capital ,Financial Services ,Two Sigma Investments ,Pieris Pharmaceuticals Daily ,Nasdaq Pirs ,Dpirs ,Medical ,Initiated Coverage ,Stocknews Com ,